Advertisement
U.S. Markets closed

XBiotech Inc. (XBIT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.57+0.02 (+0.26%)
At close: 04:00PM EDT
7.57 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 230.00M
Enterprise Value 51.47M
Trailing P/E 1.30
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.23
Price/Book (mrq)1.17
Enterprise Value/Revenue -70.30
Enterprise Value/EBITDA -1.60

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.96
52 Week Low 33.51
50-Day Moving Average 36.85
200-Day Moving Average 36.75

Share Statistics

Avg Vol (3 month) 350.57k
Avg Vol (10 day) 326.93k
Shares Outstanding 530.46M
Implied Shares Outstanding 6N/A
Float 819.83M
% Held by Insiders 135.13%
% Held by Institutions 115.06%
Shares Short (Sep 30, 2024) 4925.37k
Short Ratio (Sep 30, 2024) 417.11
Short % of Float (Sep 30, 2024) 45.19%
Short % of Shares Outstanding (Sep 30, 2024) 43.04%
Shares Short (prior month Aug 30, 2024) 4852.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 23, 2021
Ex-Dividend Date 4Jul 15, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.90%
Return on Equity (ttm)-16.44%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -41.19M
Net Income Avi to Common (ttm)-35.01M
Diluted EPS (ttm)-1.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)188.53M
Total Cash Per Share (mrq)6.19
Total Debt (mrq)10M
Total Debt/Equity (mrq)5.08
Current Ratio (mrq)11.13
Book Value Per Share (mrq)6.46

Cash Flow Statement

Operating Cash Flow (ttm)-23.5M
Levered Free Cash Flow (ttm)-18.41M